PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients

Clinical trial NCT00251849 · UNKNOWN

Trial details

NCT number: NCT00251849
Sponsor: ActivBiotics
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Peripheral Vascular Diseases Intermittent Claudication

Start date: 2005-11-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.